M33 Growth I L.P. 4
4 · Oncology Institute, Inc. · Filed May 22, 2025
Insider Transaction Report
Form 4
M33 Growth I L.P.
Director
Transactions
- Sale
Common Stock
[F1]2025-05-20$2.71/sh−1,796,468$4,873,638→ 14,624,233 total - Sale
Common Stock
[F2]2025-05-20$2.71/sh−203,532$552,162→ 1,349,048 total(indirect: See Footnote)
Footnotes (2)
- [F1]M33 Growth I GP LLC ("M33 LLC") is the general partner of M33 Growth I L.P. ("M33 LP") and may be deemed to beneficially own the shares held by M33 LP but disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein.
- [F2]These securities are held by TOI M, LLC.